abstract |
This document relates to methods and materials for treating a leukodystrophy ( e.g ., cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy; CADASIL). For example, one or more calcitonin gene-related peptide (CGRP) inhibitors can be administered to a mammal having, or at risk of developing, CADASIL to treat the mammal. |